-17.7%
MRNA vs SBAC
-45.7%
+28.0%
-93.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | SBAC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.9% | -6.5% | +2.5% | -1.7% |
| 7D | -17.6% | -8.2% | -9.3% | -15.0% |
| 30D | -5.1% | -6.1% | +0.9% | -3.2% |
| 3M | +220.8% | -2.8% | +223.7% | +223.4% |
| 6M | +321.7% | -10.8% | +332.5% | +333.5% |
| YTD | +601.3% | -7.4% | +608.6% | +601.7% |
| 1Y | +735.2% | -8.5% | +743.7% | +740.4% |
| 3Y | +170.5% | -20.3% | +190.8% | +182.1% |
| All | -17.7% | -45.7% | +28.0% | +6.6% |
Cumulative growth
Daily Returns
Daily percentage return beside SBAC.
Daily Out/Under-Performance
Portfolio return minus SBAC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling